Come on Generex Management. Give your shareholders an update on the S1s, any funding, even if it is outside of BARDA.
What else is going on with AE37, now that you put out the 10 year data information? Silence after that. That was big news. Now nothing.
Once again, Generex is in silent mode and shareholders are waiting on a CC that is coming in the 'week's, 'months'?
I know many of us are in this for long term, but like I said in the past, you can't have a long term unless you see some short term results. Right now, we need to see some short term results to know the company is moving in the right direction. So far, we have a few PRs announcing the this is what we are doing or can do, if we get funding. Everything rides on the big IF. We need to know about that big IF.
We really need to know about the S1 for NGIO. There are companies on NASDAQ who are working on all kinds of things in research, trials, etc.. They have investors. People can say what they want, but Generex needs to file that S1 for NGIO to get it listed and soon. Investors will come, funding will get there outside the government. It's works for other companies, it will work for NGIO. I just don't understand why Generex is dragging their feet, when Joe said they would be filing the S1 right after the dividend took place.
What else is going on with AE37, now that you put out the 10 year data information? Silence after that. That was big news. Now nothing.
Once again, Generex is in silent mode and shareholders are waiting on a CC that is coming in the 'week's, 'months'?
I know many of us are in this for long term, but like I said in the past, you can't have a long term unless you see some short term results. Right now, we need to see some short term results to know the company is moving in the right direction. So far, we have a few PRs announcing the this is what we are doing or can do, if we get funding. Everything rides on the big IF. We need to know about that big IF.
We really need to know about the S1 for NGIO. There are companies on NASDAQ who are working on all kinds of things in research, trials, etc.. They have investors. People can say what they want, but Generex needs to file that S1 for NGIO to get it listed and soon. Investors will come, funding will get there outside the government. It's works for other companies, it will work for NGIO. I just don't understand why Generex is dragging their feet, when Joe said they would be filing the S1 right after the dividend took place.
